BACKGROUND: Severe injury is accompanied by sympathetic stimulation that induces bone marrow (BM) dysfunction by both suppression of hematopoietic progenitor cell (HPC) growth and loss of cells via HPC mobilization to the peripheral circulation and sites of injury. Previous work demonstrated that beta-blockade (BB) given prior to tissue injury both reduces HPC mobilization and restores HPC colony growth within the BM. This study examined the effect and timing of BB on BM function in a hemorrhagic shock (HS) model. METHODS: Male Sprague-Dawley rats underwent HS via blood withdrawal, maintaining the mean arterial blood pressure at 30-40 mm Hg for 45 min, after which the extracted blood was reinfused. Propranolol (10 mg/kg) was given either prior to or immediately after HS. Blood pressure, heart rate, BM cellularity, and death were recorded. Bone marrow HPC growth was assessed by counting colony-forming unit-granulocyte-, erythrocyte-, monocyte-, megakaryocyte (CFU-GEMM), burst-forming unit-erythroid (BFU-E), and colony-forming unit-erythroid (CFU-E) cells. RESULTS: Administration of BB prior to injury restored HPC growth to that of naïve animals (CFU-GEMM 59 ± 11 vs. 61 ± 4, BFU-E 68 ± 9 vs. 73 ± 3, and CFU-E 81 ± 35 vs. 78 ± 14 colonies/plate). Beta-blockade given after HS increased the growth of CFU-GEMM, BFU-E, and CFU-E significantly and improved BM cellularity compared with HS alone. The mortality rate was not increased in the groups receiving BB. CONCLUSION: Administration of propranolol either prior to injury or immediately after resuscitation significantly reduced post-shock BM suppression. After HS, BB may improve BM cellularity by decreasing HPC mobilization. Therefore, the early use of BB post-injury may play an important role in attenuating the BM dysfunction accompanying HS.
BACKGROUND:Severe injury is accompanied by sympathetic stimulation that induces bone marrow (BM) dysfunction by both suppression of hematopoietic progenitor cell (HPC) growth and loss of cells via HPC mobilization to the peripheral circulation and sites of injury. Previous work demonstrated that beta-blockade (BB) given prior to tissue injury both reduces HPC mobilization and restores HPC colony growth within the BM. This study examined the effect and timing of BB on BM function in a hemorrhagic shock (HS) model. METHODS: Male Sprague-Dawley rats underwent HS via blood withdrawal, maintaining the mean arterial blood pressure at 30-40 mm Hg for 45 min, after which the extracted blood was reinfused. Propranolol (10 mg/kg) was given either prior to or immediately after HS. Blood pressure, heart rate, BM cellularity, and death were recorded. Bone marrow HPC growth was assessed by counting colony-forming unit-granulocyte-, erythrocyte-, monocyte-, megakaryocyte (CFU-GEMM), burst-forming unit-erythroid (BFU-E), and colony-forming unit-erythroid (CFU-E) cells. RESULTS: Administration of BB prior to injury restored HPC growth to that of naïve animals (CFU-GEMM 59 ± 11 vs. 61 ± 4, BFU-E 68 ± 9 vs. 73 ± 3, and CFU-E 81 ± 35 vs. 78 ± 14 colonies/plate). Beta-blockade given after HS increased the growth of CFU-GEMM, BFU-E, and CFU-E significantly and improved BM cellularity compared with HS alone. The mortality rate was not increased in the groups receiving BB. CONCLUSION: Administration of propranolol either prior to injury or immediately after resuscitation significantly reduced post-shock BM suppression. After HS, BB may improve BM cellularity by decreasing HPC mobilization. Therefore, the early use of BB post-injury may play an important role in attenuating the BM dysfunction accompanying HS.
Authors: Yoshio Katayama; Michela Battista; Wei-Ming Kao; Andrés Hidalgo; Anna J Peired; Steven A Thomas; Paul S Frenette Journal: Cell Date: 2006-01-27 Impact factor: 41.582
Authors: Rodrigo B Fonseca; Alicia M Mohr; Lai Wang; Erik Clinton; Ziad C Sifri; Pranela Rameshwar; David H Livingston Journal: Surg Infect (Larchmt) Date: 2004 Impact factor: 2.150
Authors: David H Livingston; Devashish Anjaria; Jonathan Wu; Carl J Hauser; Victor Chang; Edwin A Deitch; Pranela Rameshwar Journal: Ann Surg Date: 2003-11 Impact factor: 12.969
Authors: Saman Arbabi; Karla S Ahrns; Wendy L Wahl; Mark R Hemmila; Stewart C Wang; Mary-Margaret Brandt; Paul A Taheri Journal: J Trauma Date: 2004-02
Authors: Latha V Pasupuleti; Kristin M Cook; Ziad C Sifri; Srinath Kotamarti; Gabriel M Calderon; Walter D Alzate; David H Livingston; Alicia M Mohr Journal: Surgery Date: 2012-09 Impact factor: 3.982
Authors: Gregg M Baranski; Michael D Offin; Ziad C Sifri; Ihab O Elhassan; Edward J Hannoush; Walter D Alzate; Pranela Rameshwar; David H Livingston; Alicia M Mohr Journal: J Surg Res Date: 2011-04-19 Impact factor: 2.192
Authors: Alicia M Mohr; Ihab O ElHassan; Edward J Hannoush; Ziad C Sifri; Michael D Offin; Walter D Alzate; Pranela Rameshwar; David H Livingston Journal: J Trauma Date: 2011-05
Authors: Amy V Gore; Letitia E Bible; David H Livingston; Alicia M Mohr; Ziad C Sifri Journal: J Trauma Acute Care Surg Date: 2015-10 Impact factor: 3.313
Authors: John G Noel; Benjamin J Ramser; Jose A Cancelas; Francis X McCormack; Jason C Gardner Journal: Exp Hematol Date: 2017-09-01 Impact factor: 3.084
Authors: Gregg M Baranski; Ziad C Sifri; Kristen M Cook; Walter D Alzate; David H Livingston; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2012-08 Impact factor: 3.313
Authors: Letitia E Bible; Latha V Pasupuleti; Walter D Alzate; Amy V Gore; Kim J Song; Ziad C Sifri; David H Livingston; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2014-07 Impact factor: 3.313
Authors: Latha V Pasupuleti; Kristin M Cook; Ziad C Sifri; Walter D Alzate; David H Livingston; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2014-04 Impact factor: 3.313